{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T21:41:15Z","timestamp":1774474875117,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Independent Innovation Project Funds of the Central South University","award":["2017zzts895"],"award-info":[{"award-number":["2017zzts895"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12944-017-0556-9","type":"journal-article","created":{"date-parts":[[2017,9,6]],"date-time":"2017-09-06T02:30:41Z","timestamp":1504665041000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Characteristics of lipid metabolism including serum apolipoprotein M levels in patients with primary nephrotic syndrome"],"prefix":"10.1186","volume":"16","author":[{"given":"Lagu","family":"He","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengfei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bai","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhan","family":"Du","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiali","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheyi","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5317-2944","authenticated-orcid":false,"given":"Min","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,9,6]]},"reference":[{"key":"556_CR1","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet. 2003;362:629\u201339.","journal-title":"Lancet"},{"key":"556_CR2","first-page":"373","volume":"5","author":"O Tabatabaei-Malazy","year":"2014","unstructured":"Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in iran: a systematic review and meta-analysis study. Int J Prev Med. 2014;5:373\u201393.","journal-title":"Int J Prev Med."},{"key":"556_CR3","doi-asserted-by":"crossref","first-page":"31286","DOI":"10.1074\/jbc.274.44.31286","volume":"274","author":"N Xu","year":"1999","unstructured":"Xu N, Dahlback B. A novel human apolipoprotein (apoM). J Biol Chem. 1999;274:31286\u201390.","journal-title":"J Biol Chem"},{"key":"556_CR4","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1476-511X-9-102","volume":"9","author":"G Luo","year":"2010","unstructured":"Luo G, Zhang X, Mu Q, Chen L, Zheng L, Wei J, Berggren-Soderlund M, Nilsson-Ehle P, Xu N. Expression and localization of apolipoprotein M in human colorectal tissues. Lipids Health Dis. 2010;9:102.","journal-title":"Lipids Health Dis"},{"key":"556_CR5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1194\/jlr.M002162","volume":"51","author":"A Mulya","year":"2010","unstructured":"Mulya A, Seo J, Brown AL, et al. Apolipoprotein M expression increases the size of nascent prebeta-HDL formed by ATP binding cassette transporter A1. J Lipid Res. 2010;51:514\u201324.","journal-title":"J Lipid Res"},{"key":"556_CR6","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/BF00852550","volume":"7","author":"MA Thabet","year":"1993","unstructured":"Thabet MA, Salcedo JR, Chan JC. Hyperlipidemia in childhood nephrotic syndrome. Pediatr Nephrol. 1993;7:559\u201366.","journal-title":"Pediatr Nephrol"},{"key":"556_CR7","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1194\/jlr.P023697","volume":"53","author":"C Christoffersen","year":"2012","unstructured":"Christoffersen C, Benn M, Christensen PM, Gordts PL, Roebroek AJ, Frikke-Schmidt R, Tybjaerg-Hansen A, Dahlback B, Nielsen LB. The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles. J Lipid Res. 2012;53:2198\u2013204.","journal-title":"J Lipid Res"},{"issue":"6","key":"556_CR8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.3109\/00365510902980751","volume":"69","author":"P Hu","year":"2009","unstructured":"Hu P, Lu L, Hu B, et al. Characteristics of lipid metabolism under different urinary protein excretion in children with primary nephrotic syndrome. Scand J Clin Lab Invest. 2009;69(6):680\u20136.","journal-title":"Scand J Clin Lab Invest"},{"key":"556_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.47102\/annals-acadmedsg.V34N1p31","volume":"34","author":"CM Chan","year":"2005","unstructured":"Chan CM. Hyperlipidaemia in chronic kidney disease. Ann Acad Med Singap. 2005;34:31\u20135.","journal-title":"Ann Acad Med Singap"},{"key":"556_CR10","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1681\/ASN.2005121320","volume":"17","author":"R Trevisan","year":"2006","unstructured":"Trevisan R, Dodesini AR, Lepore G. Lipids and renal disease. J Am Soc Nephrol. 2006;17:S145\u20137.","journal-title":"J Am Soc Nephrol"},{"key":"556_CR11","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1097\/01.hco.0000231412.15049.fb","volume":"21","author":"AY Cheng","year":"2006","unstructured":"Cheng AY, Leiter LA. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Curr Opin Cardiol. 2006;21:400\u20134.","journal-title":"Curr Opin Cardiol"},{"key":"556_CR12","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12944-016-0325-1","volume":"15","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Zhang P. IEffects of hyperlipidaemia on plasma apolipoprotein M levels in patients with type 2 diabetes mellitus: an independent case\u2013control study. Lipids in Health Dis. 2016;15:158.","journal-title":"Lipids in Health Dis"},{"key":"556_CR13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1046\/j.1523-1755.2001.00478.x","volume":"59","author":"GC Shearer","year":"2001","unstructured":"Shearer GC, Stevenson FT, Atkinson DN, et al. Hypoalbuminemia and proteinuria contribute separately to reduced lipoprotein catabolism in the nephrotic syndrome. Kidney Int. 2001;59:179\u201389.","journal-title":"Kidney Int"},{"key":"556_CR14","doi-asserted-by":"crossref","first-page":"9613","DOI":"10.1073\/pnas.1103187108","volume":"108","author":"C Christoffersen","year":"2011","unstructured":"Christoffersen C, Obinata H, Kumaraswamy SB, Galvani S, Ahnstrom J, Sevvana M, Egerer-Sieber C, Muller YA, Hla T, Nielsen LB, Dahlback B. Endothelium-protective sphingosine-1-phosphate provided by HDL associated apolipoprotein M. Proc Natl Acad Sci U S A. 2011;108:9613\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"556_CR15","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm1211","volume":"11","author":"C Wolfrum","year":"2005","unstructured":"Wolfrum C, Poy MN, Stoffel M. Apolipoprotein M is required for prebeta-HDL formation and cholesterol efflux to HDL and protects against atherosclerosis. Nat Med. 2005;11:418\u201322.","journal-title":"Nat Med"},{"key":"556_CR16","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1074\/jbc.M704576200","volume":"283","author":"C Christoffersen","year":"2008","unstructured":"Christoffersen C, Jauhiainen M, Moser M, Porse B, Ehnholm C, Boesl M, et al. Effect of apolipoprotein M on high density lipoprotein metabolism and atherosclerosis in low density lipoprotein receptor knock-out mice. J Biol Chem. 2008;283:1839\u201347.","journal-title":"J Biol Chem"},{"key":"556_CR17","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1194\/jlr.M700471-JLR200","volume":"49","author":"J Ahnstrom","year":"2008","unstructured":"Ahnstrom J, Axler O, Jauhiainen M, Salomaa V, Havulinna AS, Ehnholm C, Frikke-Schmidt R, Tybjaerg-Hansen A, Dahlback B. Levels of apolipoprotein M are not associated with the risk of coronary heart disease in two independent case-control studies. J Lipid Res. 2008;49:1912\u20137.","journal-title":"J Lipid Res"},{"key":"556_CR18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.2337\/diabetes.48.5.937","volume":"48","author":"M Laakso","year":"1999","unstructured":"Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48:937\u201342.","journal-title":"Diabetes"},{"key":"556_CR19","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1074\/jbc.M114.596445","volume":"290","author":"M Kurano","year":"2015","unstructured":"Kurano M, Tsukamoto K, Hara M, Ohkawa R, Ikeda H, Yatomi Y. LDL receptor and ApoE are involved in the clearance of ApoM-associated sphingosine-1-phosphate. J Biol Chem. 2015;290:2477\u201388.","journal-title":"J Biol Chem"},{"key":"556_CR20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/CIRCRESAHA.109.211086","volume":"106","author":"C Christoffersen","year":"2010","unstructured":"Christoffersen C, Pedersen TX, Gordts PL, Roebroek AJ, Dahlback B, Nielsen LB. Opposing effects of apolipoprotein m on catabolism of apolipoprotein B-containing lipoproteins and atherosclerosis. Circ Res. 2010;106:1624\u201334.","journal-title":"Circ Res"},{"key":"556_CR21","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1159\/000110088","volume":"28","author":"M Tkaczyk","year":"2008","unstructured":"Tkaczyk M, Czupryniak A, Owczarek D, Lukamowicz J, Nowicki M. Markers of endothelial dysfunction in children with idiopathic nephrotic syndrome. Am J Nephrol. 2008;28:197\u2013202.","journal-title":"Am J Nephrol"},{"key":"556_CR22","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1161\/01.ATV.0000217957.93135.c2","volume":"26","author":"M Tkaczyk","year":"2006","unstructured":"Tkaczyk M, Czupryniak A, Owczarek D, Lukamowicz J, Nowicki M. Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines. Arterioscler Thromb Vasc Biol. 2006;26:1150\u20135.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"556_CR23","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1097\/01.ASN.0000015762.92814.85","volume":"13","author":"CM Hoehner","year":"2002","unstructured":"Hoehner CM, Greenlund KJ, Rith-Najarian S, Casper ML, McClellan WM. Association of the insulin resistance syndrome and microalbuminuria among nondiabetic native Americans.The inter-tribal heart project. J Am Soc Nephrol. 2002;13:1626\u201334.","journal-title":"J Am Soc Nephrol"},{"key":"556_CR24","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s40265-013-0023-5","volume":"73","author":"JM Chehade","year":"2013","unstructured":"Chehade JM, Gladysz M, Mooradian AD. Dyslipidemia in type 2 diabetes:prevalence, pathophysiology, and management. Drugs. 2013;73:327\u201339.","journal-title":"Drugs"},{"key":"556_CR25","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ndt\/gfg497","volume":"19","author":"L Vogt","year":"2004","unstructured":"Vogt L, Laverman GD, Dullaart RP, Navis G. Lipid management in the proteinuric patient: do not overlook the importance of proteinuria reduction. Nephrol Dial Transplant. 2004;19:5\u20138.","journal-title":"Nephrol Dial Transplant"},{"key":"556_CR26","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1194\/jlr.M300451-JLR200","volume":"45","author":"K Faber","year":"2004","unstructured":"Faber K, Axler O, Dahlback B, Nielsen LB. Characterization of apoM in normal and genetically modified mice. J Lipid Res. 2004;45:1272\u20138.","journal-title":"J Lipid Res"},{"key":"556_CR27","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1161\/01.ATV.14.5.707","volume":"14","author":"EA Brinton","year":"1994","unstructured":"Brinton EA, Eisenberg S, Breslow JL. Human HDL cholesterol levels are determined by apoA-I fractional catabolic rate, which correlates inversely with estimates of HDL particle size. Effects of gender, hepatic and lipoprotein lipases, triglyceride and insulin levels, and body fat distribution. Arterioscler Thromb. 1994;14:707\u201320.","journal-title":"Arterioscler Thromb"},{"issue":"2","key":"556_CR28","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10157-015-1162-7","volume":"20","author":"CP KSuresh","year":"2016","unstructured":"KSuresh CP, et al. Differentially expressed urinary biomarkers in children with idiopathic nephrotic syndrome. Clin Exp Nephrol. 2016;20(2):273\u201383.","journal-title":"Clin Exp Nephrol"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-017-0556-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T13:48:02Z","timestamp":1692971282000},"score":1,"resource":{"primary":{"URL":"http:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-017-0556-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,6]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["556"],"URL":"https:\/\/doi.org\/10.1186\/s12944-017-0556-9","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,6]]},"article-number":"167"}}